• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dexcom Inc (NQ: DXCM )

    111.72 +0.06 (+0.05%)
    Streaming Delayed Price Updated: 3:01 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 874,204
    Open 112.76
    Bid (Size) 111.69 (2)
    Ask (Size) 111.77 (2)
    Prev. Close 111.66
    Today's Range 110.75 - 113.25
    52wk Range 74.75 - 142.00
    Shares Outstanding 96,748,901
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
    Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
    Via Benzinga
    NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
    DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
    Via Chartmill

    Performance

    YTD
    -9.24%
    -9.24%
    1 Month
    -4.22%
    -4.22%
    3 Month
    -15.05%
    -15.05%
    6 Month
    -13.59%
    -13.59%
    1 Year
    -12.53%
    -12.53%

    More News

    Read More
    2 Healthcare Stocks to Buy at a Discount
    Via The Motley Fool
    What Analysts Are Saying About DexCom Stock
    Via Benzinga
    Top 4 Must-Have Healthcare Stocks for Long-Term Growth
    Via MarketBeat
    Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
    Via Benzinga
    Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
    Via Chartmill
    Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
    Via Benzinga
    3 Breakthrough Medical Device Stocks to Invest In Now
    Via InvestorPlace
    2 Top Growth Stocks to Buy With $1,000
    Via The Motley Fool
    Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
    From DexCom, Inc.
    Via Business Wire
    Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
    Via InvestorPlace
    Peering Into DexCom's Recent Short Interest
    Via Benzinga
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today
    Via Benzinga
    Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
    Via InvestorPlace
    Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
    From DexCom, Inc.
    Via Business Wire
    The 3 Best Diabetes Stocks to Buy in June 2024
    Via InvestorPlace
    What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
    Via Benzinga
    Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
    Via Investor's Business Daily
    Exposures Product Safety
    Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
    Via Benzinga
    Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
    From DexCom, Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
    From Dexcom, Inc.
    Via Business Wire
    Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
    Via The Motley Fool
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.